A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma

JOURNAL ARTICLE published 15 June 2020 in Clinical Cancer Research

Research funded by Astex Pharmaceuticals (NA)

Authors: Monica M. Mita | Patricia M. LoRusso | Kyriakos P. Papadopoulos | Michael S. Gordon | Alain C. Mita | Roberta Ferraldeschi | Harold Keer | Aram Oganesian | Xiang Yao Su | Simone Jueliger | Anthony W. Tolcher